Labcompliance On-line Audio Seminar
This seminar has been recorded and is available on CD and for
instant download. All reference material as listed below and more is
available on a special seminar website. The website is regularly
updated with most recent information. In case there are questions
related to the topic, they can be submitted through a web form and
will be answered by the speaker. For ordering info
click here.
On-line Audio Seminar 174
Implementing FDA's 'New' 21 CFR Part 11
Strategies and 10 Case Studies from
Manufacturing, Offices and Laboratories
Recorded

The FDA has changed the approach and is preparing a new major revision for Part
11. The content of the new regulation is very well defined and now is a good
time to learn what's coming and prepare your organization for the upcoming
changes. The best way to learn about Part 11 requirements and implementation is
through case studies. In this interactive seminar we will go through 10 case
studies from Pharmaceutical, Biopharmaceutical and Device Industry. All are very
well documented and the recommendations are justified. The case studies answer
all questions that frequently come up for Part 11 implementation.
Key Questions are:
-
- What are the key requirements of Part 11?
- Which ones will stay, which ones will go away?
- We already have a Part 11 program: what should we change?
- How can we be sure that we do enough but not too much?
- What is FDA's new scope and current thinking?
- Which systems should comply with Part 11
- When is electronic audit trail a 'must'?
- How to deal with legacy systems?
- How to develop and implement a gap analysis and remediation
plan?
- What is FDA's current thinking and enforcement strategy?
- How to document risk assessment for Part 11
- Where to get reference material (gap analysis, examples,
worksheets, SOPs) for easy implementation?
How does the this audio seminar help:
Answers will be presented by Dr. Ludwig Huber in a new
interactive audio seminar. During the seminar, the speaker will
present strategies and give practical recommendations. After the
seminar, an extensive list of reference material like SOPs and well
documented case studies with justifications will help immediate and
cost effective implementation.
During the interactive presentation you learn about:
- FDA's current inspection and enforcement practices: a risk
based approach
- FDA's new interpretation: learning from FDA guidance, and
recent FDA conference presentations and discussions
- Existing requirements that will go away
- New requirements of the 'new' Part 11
- Recommended changes to existing Part 11 programs to reduce
costs
- Strategy for cost-effective implementation of the 'new' Part
11:A six step plan
- Justification and documentation for the FDA and your
management
- 10 Case studies from laboratories, offices and manufacturing
with graphical workflow of records, step-by-step description,
recommendations for individual Part 11 requirements with
justifications and documentation for the FDA and your
management.
And for easy and instant implementation:
download 10+ documents from special seminar website
- Part 11 Compliance Master Plan
- Ideal to develop or update your company's Part 11 program
- 10 Case Studies
- All well documented with graphical workflow, step-by-step
description, recommendations for Part 11 requirements and and
justifications for the FDA and your management
- SOPs:
- Define and Document Scope and Controls for Part 11
- Risk Assessment for Systems Used in GxP Environments
- Training for GxP and Part 11
- Retention and Archiving of Electronic Records
- Gap analysis/checklist: 21 CFR Part 11
- Templates/examples
- Requirement Specifications for Part 11
- Most frequently asked questions and answers
- Warning letters and Inspectional observations related to 21
CFR Part11
- Recent FDA Presentation with Part11 Update
George Smith, US FDA, Member of FDA's Part11 Task Force,
Presented in April 2007
- FDA/EU Guidance documents related to electronic
records/signatures and computer validation
Who should attend?
- Part 11 groups in Bio(pharmaceutical) and device industry
- System owners
- Software developers
- IT managers and system administrators
- QA managers and personnel
- Analysts and lab managers
- Validation professionals
- Training departments
- Documentation department
- Consultants
How to order
Pick one of the options in the table that fits your needs.
|
Recorded seminar - Web download 'Site'
offer
- Multiple persons - single site
- Learn at your desk, meet in a seminar or conference room or share the
audio file and reference material at your site.
- Order includes all reference material.
|
US$ 349.-

|
|
Recorded seminar - CD
- Get the CD in your mail
- Order includes all reference material.
|
US$ 349.-

|
|
Special offer for Labcompliance
Usersclub Members
Recorded Seminar- CD or Web download.
- Order includes all reference material.
- for Usersclub information and registration,
click here
|
US$ 249.-

|
About audio seminars

Online audio seminars are presented over the
phone. During the live presentation attendees can:
- Study the printed slide material
- Watch the slides on a computer
- Watch the slides on a video screen in a seminar room
- Ask questions through email and web form
About Dr. Ludwig Huber
Dr. Ludwig Huber is the author of the Labcompliance Newsletter. He has been
conducting over 100 web and audio or video based seminars since ten years. He is
worldwide director for FDA compliance at Agilent Technologies.
|
Dr. Ludwig Huber
is a frequent presenter at IVT conferences and has been
awarded as the 'Presenter of the Year' out of 170 speakers.
This photo is from IVT's conference on Network Qualification
with Ludwig Huber as plenary speaker. |
Dr. Huber has published several books related to validation and
compliance, for example: Validation of Computerized Analytical and
Networked Systems. He was or still is a member of several
committees, e.g., of the GAMP Special interest group (SIG) on
Laboratory Computers, PDA Part 11 task force, IVT task force on
network infrastructure qualification and the European Compliance
Academy. He frequently visits FDA in Rockville, VA, and participates
in panel discussions with FDA professionals. For more information,
click here.